References:
1. Lanzillotta M,Mancuso G,Della-Torre E. Advances in the diagnosis and
management of IgG4 related disease [J].BMJ (Clinical research ed.),
2020, 369: m1067.
2. Löhr J M,Vujasinovic M,Rosendahl J, et al. IgG4-related diseases of
the digestive tract [J].Nature reviews. Gastroenterology &
hepatology, 2022, 19(3): 185-197.
3. Yu W,Freeland D M H,Nadeau K C. Food allergy: immune mechanisms,
diagnosis and immunotherapy [J].Nature reviews. Immunology, 2016,
16(12): 751-765.
4. Majumder S,Mohapatra S,Lennon R J, et al. Rituximab Maintenance
Therapy Reduces Rate of Relapse of Pancreaticobiliary Immunoglobulin
G4-related Disease [J].Clinical gastroenterology and hepatology :
the official clinical practice journal of the American
Gastroenterological Association, 2018, 16(12): 1947-1953.
5. Aringer M,Costenbader K,Daikh D, et al. 2019 European League Against
Rheumatism/American College of Rheumatology classification criteria for
systemic lupus erythematosus [J].Annals of the rheumatic diseases,
2019, 78(9): 1151-1159.
6. Umehara H,Okazaki K,Masaki Y, et al. Comprehensive diagnostic
criteria for IgG4-related disease (IgG4-RD), 2011 [J].Modern
rheumatology, 2012, 22(1): 21-30.
7. Khan S,Zhu L P,Jiang K, et al. Immunoglobulin G4-Related Disease
Manifesting as Isolated, Typical, and Nontypical Gastroesophageal
Lesion: A Research of Literature Review [J].Digestion, 2020, 101(5):
506-521.
8. Notohara K,Kamisawa T,Uchida K, et al. Gastrointestinal manifestation
of immunoglobulin G4-related disease: clarification through a
multicenter survey [J].Journal of gastroenterology, 2018, 53(7):
845-853.